259 related articles for article (PubMed ID: 15136945)
1. [Prescription of drugs without registered indication].
Wetterling T
Fortschr Neurol Psychiatr; 2004 May; 72(5):245-54. PubMed ID: 15136945
[TBL] [Abstract][Full Text] [Related]
2. [Legal decisions of german supreme courts about prescription of drugs for not registered indications ("off-label-use")].
Wetterling T
Fortschr Neurol Psychiatr; 2004 May; 72(5):255-9. PubMed ID: 15136946
[TBL] [Abstract][Full Text] [Related]
3. [Off-label use of drugs in psychiatry and neurology].
Wallesch CW
Fortschr Neurol Psychiatr; 2004 May; 72(5):243-4. PubMed ID: 15136944
[No Abstract] [Full Text] [Related]
4. [Off-label use in psychiatry].
Weih M; Thürauf N; Bleich S; Kornhuber J
Fortschr Neurol Psychiatr; 2008 Jan; 76(1):7-13. PubMed ID: 17899492
[TBL] [Abstract][Full Text] [Related]
5. [Children and adolescents with mental disorders as orphans of managed care?].
Fegert JM; Rothärmel S
Prax Kinderpsychol Kinderpsychiatr; 2000 Feb; 49(2):127-32. PubMed ID: 10721275
[TBL] [Abstract][Full Text] [Related]
6. [Off-label prescriptions. Drug use outside of established guidelines and treatment standard].
Weissbach L; Boedefeld EA
Urologe A; 2003 Mar; 42(3):428-32. PubMed ID: 12723544
[No Abstract] [Full Text] [Related]
7. A one-day survey of characteristics of off-label hospital prescription of psychotropic drugs.
Martin-Latry K; Ricard C; Verdoux H
Pharmacopsychiatry; 2007 May; 40(3):116-20. PubMed ID: 17541887
[TBL] [Abstract][Full Text] [Related]
8. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
9. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
Haw C; Stubbs J
J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
[TBL] [Abstract][Full Text] [Related]
10. [Off-label prescription of drugs in the statutory health insurance].
Niederauer HH
Gesundheitswesen; 2010 Feb; 72(2):116-9. PubMed ID: 19894208
[TBL] [Abstract][Full Text] [Related]
11. Off-label use of antipsychotics: rethinking "off-label".
Groleger U
Psychiatr Danub; 2007 Dec; 19(4):350-3. PubMed ID: 18000487
[TBL] [Abstract][Full Text] [Related]
12. Trussed in evidence? Ambiguities at the interface between clinical evidence and clinical practice.
Healy D
Transcult Psychiatry; 2009 Mar; 46(1):16-37. PubMed ID: 19293278
[TBL] [Abstract][Full Text] [Related]
13. [Increased legal liability in off-label use].
Broglie M
Aktuelle Urol; 2006 Nov; 37(6):417-9. PubMed ID: 17153265
[No Abstract] [Full Text] [Related]
14. [Who protects physicians and patients from guidelines?].
Wehling M
Dtsch Med Wochenschr; 2011 Dec; 136(49):2560-1. PubMed ID: 22131078
[No Abstract] [Full Text] [Related]
15. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
16. [Off-label use of drugs--the legal framework].
Koyuncu A
Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
[No Abstract] [Full Text] [Related]
17. Off-label prescribing in a German psychiatric hospital.
Assion HJ; Jungck C
Pharmacopsychiatry; 2007 Jan; 40(1):30-6. PubMed ID: 17327958
[TBL] [Abstract][Full Text] [Related]
18. [The importance of psychotropic drugs for gerontology].
Krebs-Roubicek E; Pöldinger W
Fortschr Med; 1990 Jan; 108(1):32-4, 37-8, 41. PubMed ID: 2179079
[TBL] [Abstract][Full Text] [Related]
19. [Off-label use: update and relevance for urology].
Krege S; Rohde D
Aktuelle Urol; 2007 Jul; 38(4):301-4. PubMed ID: 17647167
[TBL] [Abstract][Full Text] [Related]
20. [Drug monitoring and regulatory aspects of psychotropic drugs in childhood and adolescence].
Hebebrand J; Gerlach M
Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):280-2. PubMed ID: 20306786
[No Abstract] [Full Text] [Related]
[Next] [New Search]
